Deal Done!, page-95

Deal isn't bad but wouldn't say it is a company making deal.

$35m upfront is good. Wish deal total was more than $100m but close.

Non-exclusive access for many therapeutic classes was a disappointment to me as well as some of those are big eg oncology. However it is non-exclusive so not so bad.

Still feel Amgen got a good deal (the Wearables are our best device IMO) and as I said earlier, put the screws on because of our cash position, burn and SP.

$1.25 UNIS equiv to $0.30 UNS? Not bad buy in IMO.

Cadrifter's summary was great in putting the terms in layman's language, thanks

Writer's summary was good too but agree with Indi. Thought deal was underwhelming. Naish didn't expect deal to be great but I'm sure he would have loved to be wrong.

Don't think we're going to head to $1 in the immediate future but with other deals and evidence of supply, hopefully in a few quarters time.

I hope Alan remains as CEO, maybe someone else as Chairman though I guess that is an added expense.